We are live on
!
Find out more
Ensign Peak Advisors Portfolio holdings
AUM
$60.8B
1-Year Est. Return
42.06%
This Fund
S&P 500
This Quarter
Est. Return
+9.93%
1 Year Est. Return
+42.06%
3 Year Est. Return
+131.09%
5 Year Est. Return
+176.11%
10 Year Est. Return
–
AUM
$49.3B
AUM Growth
+$3.1B
(+6.7%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-1.05%
Top 10 Holdings %
Top 10 Hldgs %
27.74%
Holding
1,796
New
24
Increased
581
Reduced
361
Closed
35
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$78.5M |
| 2 |
NVIDIA
NVDA
|
+$75.6M |
| 3 |
Eli Lilly
LLY
|
+$70.2M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$58.7M |
| 5 |
Meta Platforms (Facebook)
META
|
+$55.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$107M |
| 2 |
Pfizer
PFE
|
+$70M |
| 3 |
Johnson & Johnson
JNJ
|
+$68M |
| 4 |
Danaher
DHR
|
+$56.4M |
| 5 |
Walmart Inc
WMT
|
+$54.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.47% |
| 2 | Healthcare | 17.5% |
| 3 | Financials | 11.6% |
| 4 | Consumer Discretionary | 9.63% |
| 5 | Industrials | 7.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Syndax Pharmaceuticals
SNDX
$1.84B
| $8.13M | 0.02% |
388,352
+152,982
| +65% | +$3.19M |
|
477
Moody's
MCO
$85.5B
| $8.11M | 0.02% |
23,331
+14,320
| +159% | +$4.54M |
|
478
Packaging Corp of America
PKG
$21.1B
| $8.02M | 0.02% |
60,691
+20,820
| +52% | +$2.78M |
|
479
Arcutis Biotherapeutics
ARQT
$3B
| $7.93M | 0.02% |
832,540
+346,300
| +71% | +$3.84M |
|
480
United Therapeutics
UTHR
$20.9B
| $7.91M | 0.02% |
35,810
+15,250
| +74% | +$3.38M |
|
481
Live Nation Entertainment
LYV
$40.4B
| $7.9M | 0.02% |
86,733
+19,525
| +29% | +$1.52M |
|
482
Atkore
ATKR
$3.17B
| $7.84M | 0.02% |
50,300
-29,380
| -37% | -$3.85M |
|
483
Royal Bank of Canada
RY
$292B
| $7.76M | 0.02% |
82,981
| – | – |
|
484
Evergy
EVRG
$18.8B
| $7.73M | 0.02% |
132,336
-177,080
| -57% | -$10.7M |
|
485
Trex
TREX
$4.65B
| $7.65M | 0.02% |
116,641
+7,194
| +7% | +$401K |
|
486
Ingredion
INGR
$6.39B
| $7.62M | 0.02% |
71,950
+16,955
| +31% | +$1.8M |
|
487
Prudential Financial
PRU
$42.1B
| $7.62M | 0.02% |
86,334
+51,280
| +146% | +$4.29M |
|
488
Broadridge
BR
$19.7B
| $7.58M | 0.02% |
45,767
| – | – |
|
489
Transmedics
TMDX
$3.12B
| $7.52M | 0.02% |
89,596
+6,464
| +8% | +$495K |
|
|
MRO
490
DELISTED
Marathon Oil Corporation
MRO
| $7.46M | 0.02% |
323,959
-99,355
| -23% | -$2.34M |
|
491
Molina Healthcare
MOH
$10.5B
| $7.36M | 0.01% |
24,433
-1,995
| -8% | -$573K |
|
492
Evercore
EVR
$11.5B
| $7.3M | 0.01% |
59,074
-1,430
| -2% | -$164K |
|
493
lululemon athletica
LULU
$11.1B
| $7.28M | 0.01% |
19,245
+12,295
| +177% | +$4.54M |
|
494
Delta Air Lines
DAL
$52.7B
| $7.25M | 0.01% |
152,503
-37,969
| -20% | -$1.4M |
|
495
Xylem
XYL
$24.7B
| $7.25M | 0.01% |
64,359
+6,495
| +11% | +$687K |
|
496
Cooper Companies
COO
$13.6B
| $7.25M | 0.01% |
75,612
+800
| +1% | +$75K |
|
497
Citizens Financial Group
CFG
$29.8B
| $7.23M | 0.01% |
277,127
-208,645
| -43% | -$5.75M |
|
498
Fidelity National Financial
FNF
$12.3B
| $7.18M | 0.01% |
199,420
-141,615
| -42% | -$4.94M |
|
499
Post Holdings
POST
$3.84B
| $7.12M | 0.01% |
82,176
+41,880
| +104% | +$3.67M |
|
500
Labcorp
LH
$26.5B
| $7.11M | 0.01% |
34,304
-28,595
| -45% | -$5.55M |
|
Similar funds
Ensign Peak Advisors's Q2 2023 Portfolio in Review
As of Q2 2023, Ensign Peak Advisors held 1,796 positions worth $49.3B, up 6.7% from $46.2B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 3.3%. Ensign Peak Advisors opened 24 new positions and exited 35, leaving the 1,796-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- Ensign Peak Advisors's largest Q2 2023 buy was First Horizon: 875,834 shares worth $9.87M.
- Ensign Peak Advisors added most to Microsoft in Q2 2023, an estimated $78.5M increase.
- Ensign Peak Advisors's biggest Q2 2023 reduction was AbbVie, cutting an estimated $107M.
- Ensign Peak Advisors fully exited State Street SPDR S&P 500 ETF Trust in Q2 2023, selling an estimated $45M.
- Ensign Peak Advisors's ten largest holdings make up 28% of its $49.3B portfolio in Q2 2023.
- Ensign Peak Advisors opened 24 new positions and closed 35 in Q2 2023.
- Ensign Peak Advisors's portfolio value rose 6.7% quarter-over-quarter to $49.3B.
Based on Ensign Peak Advisors's 13F filing for Q2 2023, filed 14 Aug 2023.